Skip to main
BCPC

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is projecting an increase in GAAP earnings, with expectations for $4.73 per diluted share in 2025 and $5.17 per diluted share in 2026, reflecting a positive growth trajectory bolstered by the strength in its Human Nutrition and Health segment. The company is witnessing improvements in gross and net margins, with revenue growth noted at a 9.8% increase from the previous year, driven by strong sales performance and operational efficiency. Furthermore, Balchem’s strong balance sheet positions it to potentially become debt-free by the end of the year, allowing for opportunities to pursue accretive mergers and acquisitions.

Bears say

Balchem Corporation's forecasts for earnings in 2026 have been adjusted downward to $5.10 per diluted share from a previous estimate of $5.17, reflecting weakening revenue and earnings multiples among comparable companies. The company's Human Nutrition and Health division reported fourth-quarter revenues of $166.1 million, falling short of expectations, while the Animal Nutrition and Health segment also missed targets with sales of $56.4 million. Additionally, several risks, including slower growth, inflationary pressures, and regulatory challenges related to new product launches, contribute to a cautious outlook for Balchem's financial performance.

Balchem (BCPC) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 2 analysts, Balchem (BCPC) has a Buy consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $176, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $176, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.